{
  "id": 11304252,
  "title": "Medicenna Announces Results of Annual General and Special Meeting of Shareholders",
  "url": "https://urgent.news/2026/10/01/medicenna-announces-results-of-annual-general-and-special-meeting-of",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-01T23:00:53.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/medicenna-announces-results-of-annual-general-and-special-meeting-of-shareholders"
  },
  "original_language": "en",
  "account": null,
  "summary": "TORONTO and HOUSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company developing Superkines for targeting cancer and autoimmune diseases, today announced the voting results from the Company’s annual general and special meeting of shareholders held today, October 1, 2026 (the “Meeting”).…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}